Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Advanced human skin models improve drug development and could replace animal testing.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.